 |
|
|
| |
Bone density, microarchitecture and tissue quality after 48-weeks and 96-weeks of treatment with Tenofovir Disoproxil Fumarate.
|
| |
| |
Reported by Jules Levin
19th Intl Workshop on Co-morbidities and Adverse Drug reactions
Milan, Italy Oct 23-25 2017
Robert Guerri-Fernandez1 ,Todd T. Brown2, Ana Fernandez Marron1,Judit Villar 1, Alicia Gonzalez-Mena1 , Ana Guelar 1, Elisabet Lerma-Chipirraz1 , Hernando Knobel1, Adolfo Diez-Perez1
|
| |
|
|
|
|
|
